The Dow Chemical Company
Dow Reports Second Quarter Results
Published in Healthcare Mergers, Acquisitions and Ventures Week, August 15th, 2009
-- Dow reported a loss of $0.47 per share. Excluding certain items(1) and
discontinued operations in the quarter, the Company earned $0.05 per
share, driven by favorable volume trends, management's accelerated
cost interventions and the Company's ability to maintain price from
Keywords: The Dow Chemical Company, The Dow Chemical Company.
This article was prepared by Healthcare Mergers, Acquisitions & Ventures Week editors from staff and other reports. Copyright 2009, Healthcare Mergers, Acquisitions & Ventures Week via NewsRx.com.
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 1-800-FLOWERS.COM, Inc.
Celebrate National Friendship Day With 1-800-FLOWERS.COM - 3M
3M Introduces Highly Conformable, Non-Woven Conductive Tapes - AARP
Consumer Cellular Offers AARP Members Additional Value - Abbott
Abbott and Medtronic Reach Agreement on Global Patent Disputes - Abbott
Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education - Acceleron Pharma, Inc.
Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
